HOME >> BIOLOGY >> NEWS
Long-term data on Dendreons Mylovenge vaccine presented at American Society of Hematology

Long-term data on Dendreons Mylovenge vaccine presented at American Society of Hematology Meeting

Results of Phase II studies indicate disease stabilization in patients with multiple myeloma, amyloidosis

San Francisco, CA (Dec. 2, 2000) Dendreon Corporation today announced that long-term follow-up data from Phase II trials of its therapeutic vaccine Mylovenge were presented at the American Society of Hematology Annual Meeting in San Francisco. The trials, involving patients with multiple myeloma and with amyloidosis, indicate that Mylovenge causes regression or stabilization in more than 30 percent of patients. In some patients, these benefits were found to extend more than 18 months following treatment.

Data were presented Saturday at the American Society of Hematology Annual Meeting in San Francisco by Dr. Martha Lacy of the Mayo Clinic, principal investigator of studies involving multiple myeloma and amyloidosis patients by and Dr. Malcolm MacKenzie, director of the Sacramento Medical Foundation Blood Center and principal investigator of a multi-center trial involving further patients with multiple myeloma.

In MacKenzies multicenter trial, approximately 40 percent of the 42 multiple myeloma patients evaluated have shown benefits either in terms of disease stabilization or in tumor regression. This includes six patients with decreases in serum M protein and 10 patients with disease stabilization more than six months. Four patients have been stable for more than 18 months following treatment.

In the Mayo trial of multiple myeloma patients, 17 patients were treated with Mylovenge. Clinical responses were seen in five patients, including complete or near-complete regressions. Many of these responses continued for more than one year.

In a further Mayo trial, 10 patients with amyloidosis were treated with Mylovenge. Seven had disease stabilization or regression lasting in four cases for 18 mo
'"/>

Contact: Page Sargisson
p.sargisson@noonanrusso.com
415-677-4455 x 229
Noonan/Russo Communications
1-Dec-2000


Page: 1 2

Related biology news :

1. Long-term effects of carbon monoxide poisoning are an autoimmune reaction
2. Long-term heart damage may result from constant confrontation and defeat
3. Long-term effects of embryo culture on behavior studied
4. Long-term natural gas supplies should meet growing demand in coming decades, study finds
5. Long-term decline of coral reef ecosystems reported
6. Long-term study of humans and deforestation in Amazon Basin gets new support
7. Long-term studies show most intersex adults happy with gender assignments at birth
8. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
9. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
10. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
11. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... ... July 11, 2019 , ... ... first on-site Legionella DNA test, today announced a partnership with LiquiTech, a ... , Through this strategic partnership, LiquiTech will integrate Spartan’s innovative environmental DNA ...
(Date:7/5/2019)... VIEW, Calif. (PRWEB) , ... July 05, 2019 ... ... partnering with Microsoft to bring its patented Tractus™ Platform to governments around the ... will bring cutting edge technology and point of care solutions to operating theatres ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... Dahryn Trivedi, ... physicochemical properties of Cefazolin Sodium, antibiotic which can prove to be beneficial for treating ... 519% increase in residue amount , Over 68% decrease in weight ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements ... an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for more ... educate viewers about how its technology facilitates laboratories to improve efficiency and quality ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study ... stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their ... mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. This ...
(Date:5/31/2019)... ... May 30, 2019 , ... World ... Integrity on July 08-09, 2019 in Boston, MA. This peer recommended interactive workshop ... organizations. , The training will kick off with a compendial treatment of Data ...
(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... ... in Berlin (VLB) today officially opened the inaugural Africa Brewing Conference dedicated to ... malting industry in Africa. The event, which is supported through a partnership with ...
Breaking Biology Technology:
Cached News: